FDA authorizes first at home, over the counter COVID-19 test

The FDA announced it has issued an emergency use authorization for the Cue COVID-19 test, the first at home, over the counter test for COVID-19.The agency authorized the test for non-prescription, home use in adults for self-swabbing and for children aged 2 years and older when swabbed by an adult.“The authorization of this new diagnostic test underscores FDA’s goal to continue supporting innovation in testing and providing flexibility to test developers with the aim of increasing the availability of accurate and reliable tests for all Americans,” acting FDA CommissionerRead More

Share on facebook
Share on twitter
Share on linkedin